What I would want from a home test that does not exist yet posts 31–51
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.
Post #28 put the caveat in the right place and I want to underline it.
Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which yours is comes first.
Flagging that the sources on this are thinner than the confidence in the thread suggests.
Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively.
Collapsed as off-topic by two members at trust level 3 or above
Taking post #34 at face value and following it one step further.
Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which yours is comes first.
If this contradicts something upthread, the upthread version may well be the better one.
Post #32 and I disagree about the size of the effect, not about the direction.
Nothing available at home distinguishes a correct sequence from a closely related incorrect one. That gap is fundamental rather than a matter of kit quality.
The literature is thinner on this than the confidence in the thread implies.
Photographs of test results posted here are worth including with the lighting and the timing stated, because both change the apparent result of a colorimetric method substantially.
The part I am sure of is shorter than the part I have written.
This follows post #38 rather than contradicting it.
Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes obvious sources of bias.
Coming back to post #37, because the follow-up matters more than the original answer.
Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which yours is comes first.
Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
A control sample of known material run alongside is what turns a home test from an impression into a comparison. Without one you are calibrating against memory.
Research-use-only material is not certified for anything by anybody, and no home procedure changes that. What home checks buy you is early detection of the obvious problems.
Reading it again, the caveat matters more than the finding.
Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough category, not a quantitative number.
Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide and other structurally similar compounds. The test result conflates them.
It reads as pedantry until the day it does not.
Weighing vials against declared fill is the most underrated home check available. It needs a balance with adequate resolution and it catches fill problems that no certificate would show.
Posting it because the silence on this was starting to look like agreement.
Adding the measurement that post #45 says would settle it.
Reconstitution behaviour is a legitimate home observation. A cake that will not dissolve, a solution that hazes, visible particulate — all are real information and all are free.
Second-hand, so weight it accordingly.
Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96 from 98 per cent requires instrumentation and calibration that a kit does not have.
It is one reading of the data and not the only reasonable one.
Narrowing post #49, because the general version has more than one answer.
A test that gives a yes or no on the presence of peptide bonds is answering a genuinely useful question if that is the question you had. It is not a purity assay and cannot be read as one.
That is a description of practice, not a recommendation of it.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Reflectance and photometric devices: precision in practice — a second dataset
Reflectance and photometric devices: precision in practice — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Reflectance and photometric…
|
+75 | 82 | 17k | 12h |
|
Coming back to: Why quantitation is the hard part, not detection
Why quantitation is the hard part, not detection — that is the question, and I have not found it answered plainly anywhere I have looked. Collecting what is known about quantitation in one place, because it…
|
+86 | 92 | 54k | 8mo |
|
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem
On the subject in the title: Lateral-flow and colorimetric approaches: the specificity problem Working notes rather than a conclusion. Lateral-flow and colorimetric approaches — I have the observation and I…
|
+77 | 89 | 16k | 9h |
|
Why quantitation is the hard part, not detection
Why quantitation is the hard part, not detection I have a specific reason for asking rather than idle curiosity, and the context is below. Collecting what is known about quantitation in one place, because it…
|
+11 | 15 | 27k | 12mo |
|
Reading a home test result without over-claiming
Reading a home test result without over-claiming — setting out what I have, and where I think it stops being reliable. Collecting what is known about reading a home test result in one place, because it is…
|
+124 | 137 | 19k | 7h |
Related topics — sharing the tags ELISA, documentation quality, LOD & LOQ
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
LOD and LOQ: definitions people get wrong
LOD and LOQ: definitions people get wrong — setting out what I have, and where I think it stops being reliable. What changes if the standard account of LOD and LOQ is wrong? I ask because I have been treating…
|
2 | 43k | 8mo | |
|
An inter-laboratory comparison on one lot, tabulated — what changed since
An inter-laboratory comparison on one lot, tabulated — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of inter-laboratory…
|
+24 | 28 | 3.3k | 7mo |
|
Follow-up: Why this community will not facilitate a group purchase
Why this community will not facilitate a group purchase I have a specific reason for asking rather than idle curiosity, and the context is below. Currency and fees, set out so that the comparison can be…
|
2 | 19k | 18mo | |
|
Second pass at: A payment that went through twice: how it was resolved
On the subject in the title: Second pass at: A payment that went through twice: how it was resolved Working notes rather than a conclusion. A payments question, with the mechanics separated from the money.…
|
2 | 1.1k | 14mo | |
|
Revisiting: Spike-and-recover accuracy for a peptide assay
Revisiting: Spike-and-recover accuracy for a peptide assay — setting out what I have, and where I think it stops being reliable. I was wrong about Spike-and-recover accuracy in a thread last spring and I…
|
2 | 6.8k | 21h |